Methylphenidate (Ritalin) does not improve exam performance in an experimental setting
Anke Sambeth1, Monika Toth2, Arjan Blokland2
1Department Teaching and Innovation of Learning, Faculty of Psychology and Neuroscience, Maastricht University, PO Box 616, Maastricht, 6200 MD, The Netherlands. anke.sambeth@maastrichtuniversity.nl.
Rationale:
Surveys indicate that about 10-20% of students use medicinal drugs to improve their exam performance. Whether these drugs really improve exam performance has not been examined in an experimental setting yet. This study tested the effects of methylphenidate (MPH; 20 mg) on exam performance either by giving the drug before studying for an exam (day 1, acquiring new information) or before the exam was taken (day 2, retrieving the information).
Method:
For this study, a double-blind placebo controlled between-subjects design was applied. The participants were randomly assigned to three groups that were given treatment on the two days: Placebo-Placebo (n = 25), MPH (n = 24), Placebo-MPH (n = 26). The exam contained multiple-choice questions (factual knowledge and inference questions) and open questions (inference).
Results:
The data showed that MPH did not improve the exam performance on the three types of questions. In addition, the average grade did not differ between the three groups and the number of participants failing or passing the exam did not differ.
Conclusion:
This is a first experimental study showing that MPH does not improve exam performance and should discourage students to take MPH during exam periods.
More Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
09:43The 5-Choice Serial Reaction Time Task: A Task of Attention and Impulse Control for Rodents
Published on: August 10, 2014
Related Concept Videos
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
